Opdensteinen, Patrick
Lewin, Kyle
Jain, Anshal
Copeland, Andrew
Copeland, Jonathan
Ghazinejad, Maziar
Steinmetz, Nicole F. https://orcid.org/0000-0002-0130-0481
Funding for this research was provided by:
Translational Research Institute for Space Health (NASA Cooperative Agreement NNX16AO69A)
National Institutes of Health (R01-CA274640)
Article History
Received: 30 September 2025
Accepted: 20 April 2026
First Online: 5 June 2026
Competing interests
: N.S. is a co-founder and CEO of and has equity in PlantiosX Inc. N.S. is a co-founder of and has equity in Mosaic ImmunoEngineering Inc. N.S. is a co-founder and manager of Pokometz Scientific LLC, under which she is a paid consultant to Ring Therapeutics, Inc. The other authors declare no potential competing interests.